Elongated medical catheter including marker band

Information

  • Patent Grant
  • 12220543
  • Patent Number
    12,220,543
  • Date Filed
    Wednesday, August 25, 2021
    3 years ago
  • Date Issued
    Tuesday, February 11, 2025
    4 days ago
Abstract
An elongated medical catheter includes a marker band with sidebands. The elongated medical catheter and the marker band have a radiopacity being different from the radiopacity of the sidebands.
Description
TECHNICAL FIELD

This document relates to the technical field of (and is not limited to) an elongated medical catheter including a marker band (and method therefor).


BACKGROUND

Known medical devices are configured to facilitate a medical procedure, and help healthcare providers diagnose and/or treat medical conditions of sick patients.


SUMMARY

It will be appreciated that there exists a need to mitigate (at least in part) at least one problem associated with existing (known) medical catheters. After much study of, and experimentation with, the existing (known) medical catheters, an understanding (at least in part) of the problem and its solution have been identified (at least in part) and are articulated (at least in part) as follows:


Known medical catheters (such as, known intravascular catheters, etc.) include at least one or more radiopaque marker bands (also called stripes) configured to indicate at least one position reference on the known intravascular catheters. The radiopaque marker bands are configured to be visible (detectable) under fluoroscopic imaging (by a fluoroscopic imaging system). The catheter material is loaded with (includes) a radiopaque material configured to improve visibility under fluoroscopic imaging. This is done because the materials (such as plastics) used in the known catheters may be inherently difficult to detect (see) under fluoroscopic imaging. There are physical constraints on the extent (strength) of radiopaque, and they may sometimes be challenging to visualize (under fluoroscopic imaging) in the clinic especially in small instances of the known catheters. A known method of improving visibility is to increase the visual contrast between the radiopaque marker band and the body of the known medical catheter. While this arrangement may be done by decreasing the overall radiopacity of the entire known catheter, this has the drawback of making the rest of the known catheter more difficult to visualize (under fluoroscopic imaging).


To mitigate, at least in part, at least one problem associated with the existing technology, there is provided (in accordance with a major aspect) an apparatus. The apparatus includes and is not limited to (comprises) an elongated medical catheter including a marker band with sidebands. The elongated medical catheter and the marker band have a radiopacity that is different from the radiopacity of the sidebands.


To mitigate, at least in part, at least one problem associated with the existing technology, there is provided (in accordance with a major aspect) an apparatus. The apparatus includes and is not limited to (comprises) an elongated medical catheter having a catheter distal portion and a catheter proximal portion. A marker band is positioned between the catheter distal portion and the catheter proximal portion. A first sideband is positioned proximate to the marker band. A second sideband is positioned proximate to the marker band. The radiopacity of the elongated medical catheter and the marker band is different from the radiopacity of the first sideband and the second sideband.


To mitigate, at least in part, at least one problem associated with the existing technology, there is provided (in accordance with a major aspect) a method. The method is for using an elongated medical catheter including a marker band with sidebands. The elongated medical catheter and the marker band have a radiopacity that is different from the radiopacity of the sidebands. The method includes and is not limited to (comprises) using the elongated medical catheter with a medical imaging system.


Other aspects are identified in the claims. Other aspects and features of the non-limiting embodiments may now become apparent to those skilled in the art upon review of the following detailed description of the non-limiting embodiments with the accompanying drawings. This Summary is provided to introduce concepts in simplified form that are further described below in the Detailed Description. This Summary is not intended to identify potentially key features or possible essential features of the disclosed subject matter, and is not intended to describe each disclosed embodiment or every implementation of the disclosed subject matter. Many other novel advantages, features, and relationships will become apparent as this description proceeds. The figures and the description that follow more particularly exemplify illustrative embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS

The non-limiting embodiments may be more fully appreciated by reference to the following detailed description of the non-limiting embodiments when taken in conjunction with the accompanying drawings, in which:



FIG. 1 and FIG. 2 depict a side view (FIG. 1) and a cross-sectional view (FIG. 2) of embodiments (implementations) of an elongated medical catheter; and



FIG. 3, FIG. 4 and FIG. 5 depict perspective views of embodiments (implementations) of the elongated medical catheter of FIG. 1.





The drawings are not necessarily to scale and may be illustrated by phantom lines, diagrammatic representations and fragmentary views. In certain instances, details unnecessary for an understanding of the embodiments (and/or details that render other details difficult to perceive) may have been omitted. Corresponding reference characters indicate corresponding components throughout the several figures of the drawings. Elements in the several figures are illustrated for simplicity and clarity and have not been drawn to scale. The dimensions of some of the elements in the figures may be emphasized relative to other elements for facilitating an understanding of the various disclosed embodiments. In addition, common, and well-understood, elements that are useful in commercially feasible embodiments are often not depicted to provide a less obstructed view of the embodiments of the present disclosure.












LISTING OF REFERENCE NUMERALS


USED IN THE DRAWINGS


















elongated medical catheter
 102



first catheter section
 102A



second catheter section
 102B



catheter lumen
 103



catheter distal portion
 104



catheter proximal portion
 106



marker band
 200



first end portion
 301



second end portion
 302



first sideband
 401



second sideband
 402



sidebands
(401, 402)



jig assembly
 900



heat
 902



heater
 904










DETAILED DESCRIPTION OF THE NON-LIMITING EMBODIMENT(S)

The following detailed description is merely exemplary and is not intended to limit the described embodiments or the application and uses of the described embodiments. As used, the word “exemplary” or “illustrative” means “serving as an example, instance, or illustration.” Any implementation described as “exemplary” or “illustrative” is not necessarily to be construed as preferred or advantageous over other implementations. All of the implementations described below are exemplary implementations provided to enable persons skilled in the art to make or use the embodiments of the disclosure and are not intended to limit the scope of the disclosure. The scope of the disclosure is defined by the claims. For the description, the terms “upper,” “lower,” “left,” “rear,” “right,” “front,” “vertical,” “horizontal,” and derivatives thereof shall relate to the examples as oriented in the drawings. There is no intention to be bound by any expressed or implied theory in the preceding Technical Field, Background, Summary or the following detailed description. It is also to be understood that the devices and processes illustrated in the attached drawings, and described in the following specification, are exemplary embodiments (examples), aspects and/or concepts defined in the appended claims. Hence, dimensions and other physical characteristics relating to the embodiments disclosed are not to be considered as limiting, unless the claims expressly state otherwise. It is understood that the phrase “at least one” is equivalent to “a”. The aspects (examples, alterations, modifications, options, variations, embodiments and any equivalent thereof) are described regarding the drawings. It should be understood that the disclosure is limited to the subject matter provided by the claims, and that the disclosure is not limited to the particular aspects depicted and described. It will be appreciated that the scope of the meaning of a device configured to be coupled to an item (that is, to be connected to, to interact with the item, etc.) is to be interpreted as the device being configured to be coupled to the item, either directly or indirectly. Therefore, “configured to” may include the meaning “either directly or indirectly” unless specifically stated otherwise.



FIG. 1 and FIG. 2 depict a side view (FIG. 1) and a cross-sectional view (FIG. 2) of embodiments (implementations) of an elongated medical catheter 102.


Referring to the embodiment (implementation) as depicted in FIG. 1, the elongated medical catheter 102 includes a marker band 200 with sidebands (401, 402). The elongated medical catheter 102 and the marker band 200 have a radiopacity that is different from the radiopacity of the sidebands (401, 402). Radiopacity or radiodensity is opacity to the radio wave and/or X-ray portion of the electromagnetic spectrum: that is, the relative inability of those kinds of electromagnetic radiation to pass through a particular material. The elongated medical catheter 102 includes a marker band 200 with sidebands (401, 402) that have a sufficient degree of radiopacity such that a medical imaging system is able to detect these components. The sidebands (401, 402) are, preferably, positioned on opposite sides of the marker band 200; it will be appreciated that the sidebands (401, 402) may be positioned either proximate to the opposite sides of the marker band 200, or somewhat further away (if so desired). The elongated medical catheter 102 defines a catheter lumen 103 extending along a longitudinal axis of the elongated medical catheter 102. The elongated medical catheter 102 is configured to be inserted into a confined space defined by a living body (the patient).


Referring to the embodiment (implementation) as depicted in FIG. 1, the elongated medical catheter 102 includes biocompatible material properties suitable for specific performance (such as, electric dielectric strength, electric insulation, corrosion, water resistance, heat resistance, etc.) for compliance with industrial and regulatory safety standards (or compatible for medical usage), etc. Reference is made to the following publication for consideration in the selection of a suitable material: Plastics in Medical Devices: Properties, Requirements, and Applications; 2nd Edition; author: Vinny R. Sastri; hardcover ISBN: 9781455732012; published: 21 Nov. 2013; publisher: Amsterdam [Pays-Bas]: Elsevier/William Andrew, [2014].


Referring to the embodiment (implementation) as depicted in FIG. 1, the elongated medical catheter 102 has, preferably a catheter distal portion 104 and a catheter proximal portion 106. The catheter distal portion 104 and the catheter proximal portion 106 are spaced apart from each other. The marker band 200 is, preferably, positioned between the catheter distal portion 104 and the catheter proximal portion 106. The sidebands (401, 402) include, for instance, a first sideband 401 and a second sideband 402. The first sideband 401 is positioned proximate to the marker band 200 (preferably, to one side of the marker band 200). The second sideband 402 is positioned proximate to the marker band 200 (preferably, to the other side of the marker band 200). The radiopacity of the elongated medical catheter 102 and the marker band 200 is different from the radiopacity of the first sideband 401 and the second sideband 402; this is done, preferably, in such a way that there is a contrast set up (between selected components of the elongated medical catheter 102, in which the contrast may be (readily) detected by a compatible medical-imaging system (such as, an x-ray system etc.).


Referring to the embodiment (implementation) as depicted in FIG. 1, the elongated medical catheter 102 includes a first catheter section 102A and a second catheter section 102B. The first catheter section 102A is positioned proximate to the first sideband 401. The second catheter section 102B is positioned proximate to the second sideband 402.


Referring to the embodiment (implementation) as depicted in FIG. 2, the catheter lumen 103 extends through the first sideband 401, the second sideband 402 and the marker band 200. More preferably, the catheter lumen 103 extends through the first sideband 401, the second sideband 402, the marker band 200, the first catheter section 102A and the second catheter section 102B.



FIG. 3, FIG. 4 and FIG. 5 depict perspective views of embodiments (implementations) of the elongated medical catheter 102 of FIG. 1.


Referring to the embodiment (implementation) as depicted in FIG. 3, the marker band 200 has a first end portion 301 and a second end portion 302. The first end portion 301 and the second end portion 302 are spaced apart from each other. The first sideband 401 is positioned proximate to the first end portion 301 of the marker band 200. The second sideband 402 is positioned proximate to the second end portion 302 of the marker band 200. The elongated medical catheter 102 has a catheter radiopacity. The marker band 200 has a marker-band radiopacity. The first sideband 401 has a first sideband radiopacity. The second sideband 402 has a second sideband radiopacity. The first sideband radiopacity of the first sideband 401 is less than the catheter radiopacity of the catheter 102. The second sideband radiopacity of the second sideband 402 is less than the marker-band radiopacity of the marker band 200. It will be appreciated that an equivalent to “less than” may include “different from”.


Referring to the embodiment (implementation) as depicted in FIG. 3, a first step in the manufacturing the of the elongated medical catheter 102 includes positioning the first sideband 401, the second sideband 402, the marker band 200, the first catheter section 102A and the second catheter section 102B in a spaced apart coaxial relationship.


Referring to the embodiment (implementation) as depicted in FIG. 4, a second step in the manufacturing the of the elongated medical catheter 102 includes positioning the first sideband 401, the second sideband 402, the marker band 200, the first catheter section 102A and the second catheter section 102B in an alignment relationship for insertion into an elongated jog assembly 900. The elongated jog assembly 900 is configured to securely hold these components while the components are attached to each other. Once these components are attached to each other, the lumen may be formed to extend through these components, etc.


Referring to the embodiment (implementation) as depicted in FIG. 4, a third step in the manufacturing the of the elongated medical catheter 102 includes applying heat 902 (via a heater 904) to the first sideband 401, the second sideband 402, the marker band 200, the first catheter section 102A and the second catheter section 102B after these components are positioned into the elongated jog assembly 900. The application of heat (or any type of suitable bonding method) is done in such a way that the segments become bonded to neighboring segments by melting these segments together so that they end up behaving as one piece of tubing. Gluing the segments together may be possible but might be less practical.


Referring to the embodiment (implementation) as depicted in FIG. 5, the amount of heat and the time for application of such heat should be enough to bond the second catheter section 102B with the first sideband 401, the first sideband 401 with the marker band 200, the marker band 200 with the second sideband 402, and the second sideband 402 with the first catheter section 102A.


Referring to the embodiment (implementation) as depicted in FIG. 5, the radiopacity of the elongated medical catheter 102 is reduced (preferably, only) in or at the near vicinity of the marker band 200 by reducing the proportion of, or entirely omitting, radiopaque materials in that area of the elongated medical catheter 102 located proximate to the marker band 200. As the difference between the radiopacity of the marker band 200 and elongated medical catheter 102 increases, the local contrast (visual) under fluoroscopy (under a medical imaging system) may be improved. The elongated medical catheter 102 may, advantageously, improves the visibility of the radiopaque features of the elongated medical catheter 102 (by a compatible medical-imaging system), which in turn may lead to easier use, smaller catheters and/or lower X-ray doses, etc. The elongated medical catheter 102 has a decrease in radiopacity at a near vicinity of the marker band 200; this is done in such a way that the difference in radiopacity, between the elongated medical catheter 102 and the marker band 200, is increased (at least in part). For the elongated medical catheter 102 that incorporate radiopaque fillers and/or additives into their materials, this may be achieved by reducing the radiopaque filler content near the marker band 200. The marker band 200 may have an area (zone) with a relatively higher radiopaque filler content.


The following is offered as further description of the embodiments, in which any one or more of any technical feature (described in the detailed description, the summary and the claims) may be combinable with any other one or more of any technical feature (described in the detailed description, the summary and the claims). It is understood that each claim in the claims section is an open ended claim unless stated otherwise. Unless otherwise specified, relational terms used in these specifications should be construed to include certain tolerances that the person skilled in the art would recognize as providing equivalent functionality. By way of example, the term perpendicular is not necessarily limited to 90.0 degrees, and may include a variation thereof that the person skilled in the art would recognize as providing equivalent functionality for the purposes described for the relevant member or element. Terms such as “about” and “substantially”, in the context of configuration, relate generally to disposition, location, or configuration that are either exact or sufficiently close to the location, disposition, or configuration of the relevant element to preserve operability of the element within the disclosure which does not materially modify the disclosure. Similarly, unless specifically made clear from its context, numerical values should be construed to include certain tolerances that the person skilled in the art would recognize as having negligible importance as they do not materially change the operability of the disclosure. It will be appreciated that the description and/or drawings identify and describe embodiments of the apparatus (either explicitly or inherently). The apparatus may include any suitable combination and/or permutation of the technical features as identified in the detailed description, as may be required and/or desired to suit a particular technical purpose and/or technical function. It will be appreciated that, where possible and suitable, any one or more of the technical features of the apparatus may be combined with any other one or more of the technical features of the apparatus (in any combination and/or permutation). It will be appreciated that persons skilled in the art would know that the technical features of each embodiment may be deployed (where possible) in other embodiments even if not expressly stated as such above. It will be appreciated that persons skilled in the art would know that other options may be possible for the configuration of the components of the apparatus to adjust to manufacturing requirements and still remain within the scope as described in at least one or more of the claims. This written description provides embodiments, including the best mode, and also enables the person skilled in the art to make and use the embodiments. The patentable scope may be defined by the claims. The written description and/or drawings may help to understand the scope of the claims. It is believed that all the crucial aspects of the disclosed subject matter have been provided in this document. It is understood, for this document, that the word “includes” is equivalent to the word “comprising” in that both words are used to signify an open-ended listing of assemblies, components, parts, etc. The term “comprising”, which is synonymous with the terms “including,” “containing,” or “characterized by,” is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. Comprising (comprised of) is an “open” phrase and allows coverage of technologies that employ additional, unrecited elements. When used in a claim, the word “comprising” is the transitory verb (transitional term) that separates the preamble of the claim from the technical features of the disclosure. The foregoing has outlined the non-limiting embodiments (examples). The description is made for particular non-limiting embodiments (examples). It is understood that the non-limiting embodiments are merely illustrative as examples.

Claims
  • 1. An apparatus, comprising: an elongated medical catheter including a marker band with a first sideband and a second sideband, said first and second sidebands are directly attached to opposite sides of the marker band; andwherein a catheter radiopacity of the elongated medical catheter and a marker band radiopacity of the marker band are different from a radiopacity of the first sideband and the second sideband, the radiopacity of the first sideband being less than the catheter radiopacity and the radiopacity of the second sideband being less than the marker band radiopacity.
  • 2. The apparatus of claim 1, wherein: the elongated medical catheter defines a catheter lumen extending through the sidebands and the marker band.
  • 3. The apparatus of claim 1, wherein: the catheter radiopacity decreases near the marker band.
  • 4. The apparatus of claim 3, wherein: a proportion of radiopaque materials in the elongated medical catheter near the marker band is reduced.
  • 5. The apparatus of claim 3, wherein: radiopaque materials are omitted in the elongated medical catheter near the marker band.
  • 6. An apparatus, comprising: an elongated medical catheter having a catheter distal portion and a catheter proximal portion, the catheter having a catheter radiopacity;a marker band having a first end portion and a second end portion and being positioned between the catheter distal portion and the catheter proximal portion, the marker band having a marker band radiopacity;a first sideband having a first sideband radiopacity and being directly bonded to the first end portion of the marker band; a second sideband having a second sideband radiopacity and being directly boned to the second end portion of the marker band;wherein the first sideband radiopacity is less than the catheter radiopacity and the second sideband radiopacity is less than the marker band radiopacity, and wherein the catheter radiopacity decreases near the marker band.
  • 7. The apparatus of claim 6, wherein: the elongated medical catheter defines a catheter lumen extending through the first sideband, the second sideband and the marker band.
  • 8. The apparatus of claim 6, wherein: the catheter radiopacity of the elongated medical catheter is less than the radiopacity of the marker band.
  • 9. The apparatus of claim 6, wherein: a proportion of radiopaque materials in the elongated medical catheter near the marker band is reduced.
  • 10. The apparatus of claim 6, wherein: radiopaque materials are omitted in the elongated medical catheter near the marker band.
  • 11. The apparatus of claim 6, wherein: the elongated medical catheter includes a first catheter section and a second catheter section; andthe first catheter section is positioned proximate to the first sideband; andthe second catheter section is positioned proximate to the second sideband.
  • 12. The apparatus of claim 11, wherein: the elongated medical catheter defines a catheter lumen extending through the first sideband, the second sideband, the marker band, the first catheter section and the second catheter section.
  • 13. A method of using an elongated medical catheter, the method including: providing the elongated medical catheter having a marker band and first and second sidebands, said first and second sidebands are directly attached to opposite sides of the marker band, each of the elongated medical catheter and the marker band having a radiopacity being different from a radiopacity of the first sideband and the second sideband, the radiopacity of the first sideband being less than the radiopacity of the elongated medical catheter and the radiopacity of the second sideband being less than the radiopacity of the marker band, and the radiopacity of the elongated medical catheter decreasing near the marker band; and operably coupling the elongated medical catheter with a compatible medical-imaging system.
  • 14. The method of claim 13, wherein: a proportion of radiopaque materials in the elongated medical catheter near the marker band is reduced.
  • 15. The method of claim 13, wherein: radiopaque materials are omitted in the elongated medical catheter near the marker band.
US Referenced Citations (321)
Number Name Date Kind
175254 Oberly Mar 1876 A
827626 Gillet Jul 1906 A
848711 Daniel Apr 1907 A
1072954 Junn Sep 1913 A
1279654 Charlesworth Sep 1918 A
1918094 Geekas Jul 1933 A
1996986 Weinberg Apr 1935 A
2021989 De Master Nov 1935 A
2146636 Lipchow Feb 1939 A
3429574 Williams Feb 1969 A
3448739 Stark et al. Jun 1969 A
3575415 Fulp et al. Apr 1971 A
3595239 Petersen Jul 1971 A
4129129 Amrine Dec 1978 A
4244362 Anderson Jan 1981 A
4401124 Guess et al. Aug 1983 A
4639252 Kelly et al. Jan 1987 A
4641649 Walinsky et al. Feb 1987 A
4669467 Willett et al. Jun 1987 A
4682596 Bales et al. Jul 1987 A
4790311 Ruiz Dec 1988 A
4790809 Kuntz Dec 1988 A
4793350 Mar et al. Dec 1988 A
4807620 Strul et al. Feb 1989 A
4832048 Cohen May 1989 A
4840622 Hardy Jun 1989 A
4863441 Lindsay et al. Sep 1989 A
4884567 Elliott et al. Dec 1989 A
4892104 Ito et al. Jan 1990 A
4896671 Cunningham et al. Jan 1990 A
4928693 Goodin et al. May 1990 A
4936281 Stasz Jun 1990 A
4960410 Pinchuk Oct 1990 A
4977897 Hurwitz Dec 1990 A
4998933 Eggers et al. Mar 1991 A
5006119 Acker et al. Apr 1991 A
5019076 Yamanashi et al. May 1991 A
5047026 Rydell Sep 1991 A
5081997 Bosley et al. Jan 1992 A
5098431 Rydell Mar 1992 A
5112048 Kienle May 1992 A
5154724 Andrews Oct 1992 A
5201756 Horzewski et al. Apr 1993 A
5209741 Spaeth May 1993 A
5211183 Wilson May 1993 A
5221256 Mahurkar Jun 1993 A
5230349 Langberg Jul 1993 A
5281216 Klicek Jan 1994 A
5300068 Rosar et al. Apr 1994 A
5300069 Hunsberger et al. Apr 1994 A
5314418 Takano et al. May 1994 A
5318525 West et al. Jun 1994 A
5327905 Avitall Jul 1994 A
5364393 Auth et al. Nov 1994 A
5372596 Klicek et al. Dec 1994 A
5380304 Parker Jan 1995 A
5397304 Truckai Mar 1995 A
5403338 Milo Apr 1995 A
5423809 Klicek Jun 1995 A
5425382 Golden et al. Jun 1995 A
5490859 Mische et al. Feb 1996 A
5497774 Swartz et al. Mar 1996 A
5507751 Goode et al. Apr 1996 A
5509411 Littmann et al. Apr 1996 A
5540681 Strul et al. Jul 1996 A
5545200 West et al. Aug 1996 A
5555618 Winkler Sep 1996 A
5571088 Lennox et al. Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575772 Lennox Nov 1996 A
5599347 Hart et al. Feb 1997 A
5605162 Mirzaee et al. Feb 1997 A
5617878 Taheri Apr 1997 A
5622169 Golden et al. Apr 1997 A
5624430 Eton et al. Apr 1997 A
5667488 Lundquist et al. Sep 1997 A
5673695 Mcgee et al. Oct 1997 A
5674208 Berg et al. Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5720744 Eggleston et al. Feb 1998 A
5741249 Moss et al. Apr 1998 A
5766135 Terwilliger Jun 1998 A
5779688 Imran et al. Jul 1998 A
5810764 Eggers et al. Sep 1998 A
5814028 Swartz et al. Sep 1998 A
5830214 Flom et al. Nov 1998 A
5836875 Webster, Jr. Nov 1998 A
5849011 Jones et al. Dec 1998 A
5851210 Torossian Dec 1998 A
5885227 Finlayson Mar 1999 A
5888201 Stinson et al. Mar 1999 A
5893848 Negus et al. Apr 1999 A
5893885 Webster, Jr. Apr 1999 A
5904679 Clayman May 1999 A
5916210 Winston Jun 1999 A
5921957 Killion et al. Jul 1999 A
5931818 Werp et al. Aug 1999 A
5944023 Johnson et al. Aug 1999 A
5951482 Winston et al. Sep 1999 A
5957842 Littmann et al. Sep 1999 A
5964757 Ponzi Oct 1999 A
5967976 Larsen et al. Oct 1999 A
5989276 Houser et al. Nov 1999 A
6007555 Devine Dec 1999 A
6009877 Edwards Jan 2000 A
6013072 Winston et al. Jan 2000 A
6017340 Cassidy et al. Jan 2000 A
6018676 Davis et al. Jan 2000 A
6030380 Auth et al. Feb 2000 A
6032674 Eggers et al. Mar 2000 A
6048349 Winston et al. Apr 2000 A
6053870 Fulton, III Apr 2000 A
6053904 Scribner et al. Apr 2000 A
6056747 Saadat et al. May 2000 A
6063093 Winston et al. May 2000 A
6093185 Ellis et al. Jul 2000 A
6106515 Winston et al. Aug 2000 A
6106520 Laufer et al. Aug 2000 A
6117131 Taylor Sep 2000 A
6142992 Cheng et al. Nov 2000 A
6146380 Racz et al. Nov 2000 A
6155264 Ressemann et al. Dec 2000 A
6156031 Aita et al. Dec 2000 A
6171305 Sherman Jan 2001 B1
6179824 Eggers et al. Jan 2001 B1
6193676 Winston et al. Feb 2001 B1
6193715 Wrublewski et al. Feb 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6217575 Devore et al. Apr 2001 B1
6221061 Engelson et al. Apr 2001 B1
6228076 Winston et al. May 2001 B1
6245054 Fuimaono et al. Jun 2001 B1
6267758 Daw et al. Jul 2001 B1
6283983 Makower et al. Sep 2001 B1
6292678 Hall et al. Sep 2001 B1
6293945 Parins et al. Sep 2001 B1
6296615 Brockway et al. Oct 2001 B1
6296636 Cheng et al. Oct 2001 B1
6302898 Edwards et al. Oct 2001 B1
6304769 Arenson et al. Oct 2001 B1
6315777 Comben Nov 2001 B1
6328699 Eigler et al. Dec 2001 B1
6360128 Kordis et al. Mar 2002 B2
6364877 Goble et al. Apr 2002 B1
6385472 Hall et al. May 2002 B1
6394976 Winston et al. May 2002 B1
6395002 Ellman et al. May 2002 B1
6419674 Bowser et al. Jul 2002 B1
6428551 Hall et al. Aug 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6475214 Moaddeb Nov 2002 B1
6485485 Winston et al. Nov 2002 B1
6508754 Liprie et al. Jan 2003 B1
6524303 Garibaldi Feb 2003 B1
6530923 Dubrul et al. Mar 2003 B1
6554827 Chandrasekaran et al. Apr 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6562049 Norlander et al. May 2003 B1
6565562 Shah et al. May 2003 B1
6607529 Jones et al. Aug 2003 B1
6632222 Edwards et al. Oct 2003 B1
6639999 Cookingham et al. Oct 2003 B1
6650923 Lesh et al. Nov 2003 B1
6651672 Roth Nov 2003 B2
6662034 Segner et al. Dec 2003 B2
6663621 Winston et al. Dec 2003 B1
6702811 Stewart et al. Mar 2004 B2
6709444 Makower Mar 2004 B1
6723052 Mills Apr 2004 B2
6733511 Hall et al. May 2004 B2
6740103 Hall et al. May 2004 B2
6752800 Winston et al. Jun 2004 B1
6755816 Ritter et al. Jun 2004 B2
6811544 Schaer Nov 2004 B2
6814733 Schwartz et al. Nov 2004 B2
6820614 Bonutti Nov 2004 B2
6834201 Gillies et al. Dec 2004 B2
6842639 Winston et al. Jan 2005 B1
6852109 Winston et al. Feb 2005 B2
6855143 Davison et al. Feb 2005 B2
6860856 Ward et al. Mar 2005 B2
6869431 Maguire et al. Mar 2005 B2
6911026 Hall et al. Jun 2005 B1
6951554 Johansen et al. Oct 2005 B2
6951555 Suresh et al. Oct 2005 B1
6955675 Jain Oct 2005 B2
6970732 Winston et al. Nov 2005 B2
6980843 Eng et al. Dec 2005 B2
7029470 Francischelli et al. Apr 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7083566 Tornes et al. Aug 2006 B2
7112197 Hartley et al. Sep 2006 B2
7335197 Sage et al. Feb 2008 B2
7618430 Scheib Nov 2009 B2
7651492 Wham Jan 2010 B2
7666203 Chanduszko et al. Feb 2010 B2
7678081 Whiting et al. Mar 2010 B2
7682360 Guerra Mar 2010 B2
7828796 Wong et al. Nov 2010 B2
7900928 Held et al. Mar 2011 B2
8192425 Mirza et al. Jun 2012 B2
8257323 Joseph et al. Sep 2012 B2
8388549 Paul et al. Mar 2013 B2
8500697 Kurth et al. Aug 2013 B2
9592100 Olson Mar 2017 B2
11339579 Stearns May 2022 B1
20010012934 Chandrasekaran et al. Aug 2001 A1
20010021867 Kordis et al. Sep 2001 A1
20020019644 Hastings et al. Feb 2002 A1
20020022781 McLntire et al. Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020087153 Roschak et al. Jul 2002 A1
20020087156 Maguire et al. Jul 2002 A1
20020111618 Stewart et al. Aug 2002 A1
20020123749 Jain Sep 2002 A1
20020147485 Mamo et al. Oct 2002 A1
20020169377 Khairkhahan et al. Nov 2002 A1
20020188302 Berg et al. Dec 2002 A1
20020198521 MaGuire Dec 2002 A1
20030032929 McGuckin Feb 2003 A1
20030040742 Underwood et al. Feb 2003 A1
20030144658 Schwartz et al. Jul 2003 A1
20030158480 Tornes et al. Aug 2003 A1
20030163153 Scheib Aug 2003 A1
20030225392 McMichael et al. Dec 2003 A1
20040015162 McGaffigan Jan 2004 A1
20040024396 Eggers Feb 2004 A1
20040030328 Eggers et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040073243 Sepetka et al. Apr 2004 A1
20040077948 Violante et al. Apr 2004 A1
20040116851 Johansen et al. Jun 2004 A1
20040127963 Uchida et al. Jul 2004 A1
20040133113 Krishnan Jul 2004 A1
20040133130 Ferry et al. Jul 2004 A1
20040143256 Bednarek Jul 2004 A1
20040147950 Mueller et al. Jul 2004 A1
20040176682 Murphy Sep 2004 A1
20040181213 Gondo Sep 2004 A1
20040230188 Cioanta et al. Nov 2004 A1
20050004585 Hall et al. Jan 2005 A1
20050010208 Winston et al. Jan 2005 A1
20050049628 Schweikert et al. Mar 2005 A1
20050059966 McClurken et al. Mar 2005 A1
20050065507 Hartley et al. Mar 2005 A1
20050085806 Auge et al. Apr 2005 A1
20050096529 Cooper et al. May 2005 A1
20050101984 Chanduszko et al. May 2005 A1
20050113686 Peckham May 2005 A1
20050119556 Gillies et al. Jun 2005 A1
20050137527 Kunin Jun 2005 A1
20050143770 Carter Jun 2005 A1
20050149012 Penny et al. Jul 2005 A1
20050203504 Wham et al. Sep 2005 A1
20050203507 Truckai et al. Sep 2005 A1
20050261607 Johansen et al. Nov 2005 A1
20050288631 Lewis et al. Dec 2005 A1
20060041253 Newton et al. Feb 2006 A1
20060074398 Whiting et al. Apr 2006 A1
20060079769 Whiting et al. Apr 2006 A1
20060079787 Whiting et al. Apr 2006 A1
20060079884 Manzo et al. Apr 2006 A1
20060085054 Zikorus et al. Apr 2006 A1
20060089638 Carmel et al. Apr 2006 A1
20060106375 Werneth et al. May 2006 A1
20060135962 Kick et al. Jun 2006 A1
20060142756 Davies et al. Jun 2006 A1
20060189972 Grossman Aug 2006 A1
20060241586 Wilk Oct 2006 A1
20060247672 Vidlund et al. Nov 2006 A1
20060264927 Ryan Nov 2006 A1
20060276710 Krishnan Dec 2006 A1
20070060879 Weitzner et al. Mar 2007 A1
20070066975 Wong et al. Mar 2007 A1
20070118099 Trout, III May 2007 A1
20070123964 Davies et al. May 2007 A1
20070167775 Kochavi et al. Jul 2007 A1
20070208256 Marilla Sep 2007 A1
20070225681 House Sep 2007 A1
20070270791 Wang et al. Nov 2007 A1
20080039865 Shaher et al. Feb 2008 A1
20080042360 Veikley Feb 2008 A1
20080086120 Mirza et al. Apr 2008 A1
20080097213 Carlson et al. Apr 2008 A1
20080108987 Bruszewski et al. May 2008 A1
20080146918 Magnin et al. Jun 2008 A1
20080171934 Greenan et al. Jul 2008 A1
20080208121 Youssef et al. Aug 2008 A1
20080275439 Francischelli et al. Nov 2008 A1
20090105742 Kurth et al. Apr 2009 A1
20090138009 Viswanathan et al. May 2009 A1
20090163850 Betts et al. Jun 2009 A1
20090177114 Chin et al. Jul 2009 A1
20090264977 Bruszewski et al. Oct 2009 A1
20100087789 Leeflang et al. Apr 2010 A1
20100125282 Machek et al. May 2010 A1
20100168684 Ryan Jul 2010 A1
20100179632 Bruszewski et al. Jul 2010 A1
20100191142 Paul et al. Jul 2010 A1
20100194047 Sauerwine Aug 2010 A1
20110046619 Ducharme Feb 2011 A1
20110152716 Chudzik et al. Jun 2011 A1
20110160592 Mitchell Jun 2011 A1
20110190763 Urban et al. Aug 2011 A1
20120232546 Mirza et al. Sep 2012 A1
20120265055 Melsheimer et al. Oct 2012 A1
20120330156 Brown et al. Dec 2012 A1
20130184551 Paganelli et al. Jul 2013 A1
20130184735 Fischell et al. Jul 2013 A1
20130282084 Mathur et al. Oct 2013 A1
20140206987 Urbanski et al. Jul 2014 A1
20140296769 Hyde et al. Oct 2014 A1
20160220741 Garrison et al. Aug 2016 A1
20160250444 Lampropoulos Sep 2016 A1
20170095646 Norman Apr 2017 A1
20170333149 Stigall Nov 2017 A1
20190021763 Zhou et al. Jan 2019 A1
20190247035 Gittard et al. Aug 2019 A1
20200038207 Simpson Feb 2020 A1
20210106308 Stigall Apr 2021 A1
Related Publications (1)
Number Date Country
20220072274 A1 Mar 2022 US
Provisional Applications (1)
Number Date Country
63076535 Sep 2020 US